CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,447 | +66.0% | 21,468 | +11.4% | 0.02% | -50.0% |
| Q2 2021 | $381,000 | -43.4% | 19,266 | -38.0% | 0.03% | -25.6% |
| Q3 2020 | $673,000 | -31.8% | 31,092 | -25.7% | 0.04% | -37.7% |
| Q2 2020 | $987,000 | +26.5% | 41,873 | -36.7% | 0.07% | +21.1% |
| Q1 2020 | $780,000 | +140.0% | 66,125 | +115.9% | 0.06% | +200.0% |
| Q4 2019 | $325,000 | +16.9% | 30,632 | -30.4% | 0.02% | +11.8% |
| Q4 2018 | $278,000 | +135.6% | 44,016 | +204.2% | 0.02% | +30.8% |
| Q4 2017 | $118,000 | -22.9% | 14,470 | +37.1% | 0.01% | -66.7% |
| Q3 2017 | $153,000 | -15.5% | 10,556 | -29.3% | 0.04% | -22.0% |
| Q2 2017 | $181,000 | -77.4% | 14,931 | -76.1% | 0.05% | -51.5% |
| Q1 2017 | $802,000 | +1.3% | 62,381 | -44.5% | 0.10% | +10.8% |
| Q1 2016 | $792,000 | +109.5% | 112,403 | +99.7% | 0.09% | +121.4% |
| Q2 2015 | $378,000 | – | 56,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |